MA29513B1 - Nouveau produit, procede et intermediaires de preparation de derives d'azetidine - Google Patents

Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Info

Publication number
MA29513B1
MA29513B1 MA29896A MA29896A MA29513B1 MA 29513 B1 MA29513 B1 MA 29513B1 MA 29896 A MA29896 A MA 29896A MA 29896 A MA29896 A MA 29896A MA 29513 B1 MA29513 B1 MA 29513B1
Authority
MA
Morocco
Prior art keywords
intermediates
new product
azetidine derivatives
preparing azetidine
preparing
Prior art date
Application number
MA29896A
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Luc Grondard
Joel Malpart
Joerg Rieke-Zapp
Veronique Crocq
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MA29513B1 publication Critical patent/MA29513B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouveau procédé de préparation de dérivés d'azétidine tels que le N-{l-[bis-(4-chlorophényl)méthyl]azétidin-3-yl}-N-quinol-6-yl-méthylsulfonamide et de son dichlorhydrate et du N-{l-[bis-(4-chlorophényl)méthyl]azétidin-3-yl}-N-(3,5-difluorophényl)-méthylsulfonamide.
MA29896A 2004-10-14 2007-05-11 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine MA29513B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
MA29513B1 true MA29513B1 (fr) 2008-06-02

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29896A MA29513B1 (fr) 2004-10-14 2007-05-11 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Country Status (21)

Country Link
US (1) US7687493B2 (fr)
EP (1) EP1805167A2 (fr)
JP (1) JP2008516932A (fr)
KR (1) KR20070063544A (fr)
CN (1) CN101039931A (fr)
AR (1) AR051390A1 (fr)
AU (1) AU2005293454A1 (fr)
BR (1) BRPI0516507A (fr)
CA (1) CA2583992A1 (fr)
EA (1) EA011408B1 (fr)
EC (1) ECSP077332A (fr)
FR (1) FR2876688B1 (fr)
IL (1) IL181904A0 (fr)
MA (1) MA29513B1 (fr)
MX (1) MX2007003923A (fr)
NO (1) NO20072192L (fr)
SG (1) SG155193A1 (fr)
TN (1) TNSN07097A1 (fr)
TW (1) TW200630358A (fr)
WO (1) WO2006040465A2 (fr)
ZA (1) ZA200702528B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
AU7775401A (en) * 2000-08-10 2002-02-25 Welfide Corp Proline derivatives and use thereof as drugs
CN101407471A (zh) * 2003-08-29 2009-04-15 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
AU2005293454A1 (en) 2006-04-20
FR2876688A1 (fr) 2006-04-21
SG155193A1 (en) 2009-09-30
KR20070063544A (ko) 2007-06-19
CA2583992A1 (fr) 2006-04-20
TW200630358A (en) 2006-09-01
US20070270463A1 (en) 2007-11-22
IL181904A0 (en) 2007-07-04
US7687493B2 (en) 2010-03-30
NO20072192L (no) 2007-04-27
EP1805167A2 (fr) 2007-07-11
AR051390A1 (es) 2007-01-10
FR2876688B1 (fr) 2007-03-16
EA200700840A1 (ru) 2007-08-31
EA011408B1 (ru) 2009-02-27
ECSP077332A (es) 2007-04-26
WO2006040465A3 (fr) 2006-08-10
TNSN07097A1 (fr) 2008-06-02
WO2006040465A2 (fr) 2006-04-20
CN101039931A (zh) 2007-09-19
BRPI0516507A (pt) 2008-09-16
JP2008516932A (ja) 2008-05-22
MX2007003923A (es) 2007-06-07
ZA200702528B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
FR2851563B1 (fr) Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
HK1145684A1 (en) Process for preparing benzofurans
HK1062888A1 (en) Vinyl phenyl derivatives as glk activators
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
MA29620B1 (fr) Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede pour sa preparation, medicaments contenant ce compose, et son utilisation
ES2141688A1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
YU50902A (sh) Novi estri izvedeni iz (rr,ss)-3-(2-dimetilaminometil-1-hidroksicikloheksil)fenil 2-hidroksibenzoata
TW200519106A (en) Organic compounds
UA89787C2 (ru) Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение
MXPA04003007A (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
YU46903A (sh) Derivati difenil-azetidinona,postupak za njihovu proizvodnju lekovi koji sadrže ova jedinjenja i njihova primena
TW200602338A (en) Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions
YU47803A (sh) Derivati difenil-azetidinona, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
EA200300970A1 (ru) Энантиоселективный синтез промежуточных соединений для получения азетидинонов
MX2007004637A (es) Sintesis asimetrica de derivados de dihidrobenzofurano.
MX2007006322A (es) Dihidrato de clorhidrato de (s)-(-)-1-(4-fluoroisoquinolin-5-il) sulfonil-2-metil-1,4-homopiperazina.
KR970705542A (ko) 신경보호성 3-(피페리디닐-1)-크로만-4,7-디올 및 1-(4-하이드로페닐)-2-(피페리디닐-1)-알칸올 유도체(neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
MA29513B1 (fr) Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
TNSN07115A1 (fr) Procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide
WO2004106307A3 (fr) Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
NO20055495L (no) 4-(4-trans-hydroksysykloheksyl)amino-2-fenyl-7H-pyrrolo[2,3-d]-pyrimidinhydrogenmesylat og dets polymorfe former
WO2003106440A3 (fr) Procede de synthese d'un derive benzamide
MXPA05009122A (es) Derivados de acido benzoilureidopiridil-piperidin-y pirrolidin-carboxilico sustituido, metodo para su produccion y su uso.